Shining D' light on chronic kidney disease: Mechanisms that may underpin the cardiovascular benefit of vitamin D

Therapeutic Effects of Vitamin D Analogs on Cardiac Hypertrophy in Spontaneously Hypertensive Rats

(2010) Juan Kong et al.   AMERICAN JOURNAL OF PATHOLOGY

Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin–angiotensin system

(2010) Andreas Tomaschitz et al.   CLINICA CHIMICA ACTA

Cholecalciferol Supplementation in Hemodialysis Patients: Effects on Mineral Metabolism, Inflammation, and Cardiac Dimension Parameters

(2010) P. J. Matias et al.   Clinical Journal of the American Society of Nephrology

Cardiovascular Death in Dialysis Patients: Lessons We Can Learn from AURORA

(2010) A. D. Sniderman et al.   Clinical Journal of the American Society of Nephrology

FGF-23: More than a regulator of renal phosphate handling?

(2010) Harald Jüppner et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

(2010) Dick de Zeeuw et al.   LANCET

The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?

(2010) T. E. Larsson   NEPHROLOGY DIALYSIS TRANSPLANTATION

Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial

(2009) Steven Fishbane et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

1,25-Dihydroxyvitamin D3 Prevents Puromycin Aminonucleoside-Induced Apoptosis of Glomerular Podocytes by Activating the Phosphatidylinositol 3-Kinase/Akt-Signaling Pathway

(2009) Houqin Xiao et al.   AMERICAN JOURNAL OF NEPHROLOGY

Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial

(2009) Pamela R. von Hurst et al.   BRITISH JOURNAL OF NUTRITION

Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults

(2009) R D Semba et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease

(2009) M. L. Melamed et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy

(2009) Xiaoyue Tan et al.   KIDNEY INTERNATIONAL

Chronic kidney disease, hypovitaminosis D, and mortality in the United States

(2009) Rajnish Mehrotra et al.   KIDNEY INTERNATIONAL

Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial

(2008) Cheuk-Chun Szeto et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population

(2008) M. L. Melamed et al.   ARCHIVES OF INTERNAL MEDICINE

25-Hydroxyvitamin D and Risk of Myocardial Infarction in MenA Prospective Study

(2008) Edward Giovannucci   ARCHIVES OF INTERNAL MEDICINE

Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular Mortality

(2008) Harald Dobnig   ARCHIVES OF INTERNAL MEDICINE

Vitamin D Deficiency and Risk of Cardiovascular Disease

(2008) Thomas J. Wang et al.   CIRCULATION

Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease

(2008) Daijo Inaguma et al.   Clinical and Experimental Nephrology

Physiology and pharmacology of the (pro)renin receptor

(2008) G NGUYEN et al.   CURRENT OPINION IN PHARMACOLOGY

Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease

(2008) Pooneh Alborzi et al.   HYPERTENSION

Vitamin D, the renin-angiotensin system, and insulin resistance

(2008) George Rammos et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus

(2008) Ippei Kanazawa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of Vitamin D [25(OH)D] Deficiency and Effects of Supplementation With Ergocalciferol (Vitamin D2) in Stage 5 Chronic Kidney Disease Patients

(2008) Debra Blair et al.   JOURNAL OF RENAL NUTRITION

Vitamin D Status of Chronic Kidney Disease Patients Living in a Sunny Country

(2008) Lilian Cuppari et al.   JOURNAL OF RENAL NUTRITION

Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF- B Signaling

(2008) X. Tan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Association of Oral Calcitriol with Improved Survival in Nondialyzed CKD

(2008) A. B. Shoben et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Oral active vitamin D is associated with improved survival in hemodialysis patients

(2008) Manuel Naves-Díaz et al.   KIDNEY INTERNATIONAL

Suppression of renin–angiotensin gene expression in the kidney by paricalcitol

(2008) Michael Freundlich et al.   KIDNEY INTERNATIONAL

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1α-hydroxylase knockout mice

(2008) Chunlei Zhou et al.   KIDNEY INTERNATIONAL

Vitamin D levels and patient outcome in chronic kidney disease

(2008) Pietro Ravani et al.   KIDNEY INTERNATIONAL

Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats

(2008) N. Koleganova et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D3 stimulation

(2008) N. Maruotti et al.   RHEUMATOLOGY INTERNATIONAL

Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography

(2008) Stefan Pilz et al.   STROKE

Role of vitamin D in the pathogenesis of type 2 diabetes mellitus

(2007) X. Palomer et al.   DIABETES OBESITY & METABOLISM